MedTrace Logo

Vitamin D Replacement: The Effect on Statin-Related Myalgias

NCT01022398 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2013-05-20

Study results available
· View outcomes & findings →

Summary

The purpose of this project is to determine if Vitamin D supplementation \[10,000 international units of cholecalciferol (vitamin D3) by mouth weekly\] will decrease the rate of discontinuation of statin therapy due to muscle ache/pain and decrease the occurrence of muscle ache/pain due to statin therapy.

Conditions

  • HMG-CoA Reductase Inhibitors-related Myalgias

Interventions

DRUG

cholecalciferol/placebo

10,000 IU by mouth weekly for 6 months

Sponsors & Collaborators

  • Creighton University

    lead OTHER

Principal Investigators

  • Susan Schima, MD · Creighton University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01022398 on ClinicalTrials.gov